Cited by 36Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

Involvement of WAVE Accumulation in Aβ/APP Pathology-Dependent Tangle Modification in Alzheimer’s Disease

Open access
Takata, Kazuyuki, Kitamura, Yoshihisa, Nakata, Yukinori, Matsuoka, Yasuji, Tomimoto, Hidekazu, Taniguchi, Takashi, Shimohama, Shun·2009·The American Journal of Pathology

Abstract

Synaptic deficits are closely correlated with cognitive dysfunction in Alzheimer's disease (AD), and synaptic integrity is regulated by the actin cytoskeleton. We demonstrated here that the Wiskott-Aldrich syndrome protein family verprolin-homologous protein (WAVE), a key molecule for actin assembly, co-aggregated with both hyperphosphorylated tau and phosphorylated collapsin response mediator protein 2 (CRMP2) in neurofibrillary tangles and abnormal neurites of the AD brain. Although phosphorylated CRMP2 accumulation was induced in the brains of JNPL3 mice, WAVE accumulation was not detected in the brains of either JNPL3 or Tg2576 mice that developed neurofibrillary tangles and amyloid-beta (Abeta) plaques, respectively. Interestingly, both phosphorylated CRMP2 accumulation and WAVE accumulation were recapitulated in the brains of 3xTg-AD mice that developed neurofibrillary tangles and Abeta plaques. In addition, we found an interaction between WAVE, CRMP2, and hyperphosphorylated tau in the cytosolic fraction of the AD brain. Taken together, WAVE accumulation may require both Abeta/amyloid precursor protein and tau pathologies, and an interaction between WAVE, CRMP2, and hyperphosphorylated tau may be involved in this process. Thus, WAVE accumulation may be involved in Abeta/amyloid precursor protein mediated-tangle modification, suggesting a possible correlation between WAVE accumulation and synaptic deficits induced by disturbances in actin assembly in AD brains.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2353/ajpath.2009.080908

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The colocalization of WAVE1 protein or phosphorylated WAVE1 with aggregated hyperphosphorylated tau was observed in the brains of triple transgenic mice and human AD patients.

    “The colocalization of the WAVE1 protein or phosphorylated WAVE1 with aggregated hyperphosphorylated tau was observed in the brains of triple transgenic mice (APPswe/PS1M146V/tauP301L)47 and human AD patients147.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 27

  1. Ihara Y, Nukina N, Miura R, Ogawara M: Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer's disease. J Biochem 1986, 99:1807-1810
  2. McKee AC, Kowall NW, Kosik KS: Microtubular reorganization and dendritic growth response in Alzheimer's disease. Ann Neurol 1989, 26:652-659
  3. Rodriguez OC, Schaefer AW, Mandato CA, Forscher P, Bement WM, Waterman-Storer CM: Conserved microtubule-actin interactions in cell movement and morphogenesis. Nat Cell Biol 2003, 5:599 -609
  4. Pilpel Y, Segal M: Rapid WAVE dynamics in dendritic spines of cultured hippocampal neurons is mediated by actin polymerization. J Neurochem 2005, 95:1401-1410
  5. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R: Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991, 30:572-580
  6. Miki H, Suetsugu S, Takenawa T: WAVE, a novel WASP-family protein involved in actin reorganization induced by Rac. EMBO J 1998, 17:6932-6941
  7. Dahl JP, Wang-Dunlop J, Gonzales C, Goad ME, Mark RJ, Kwak SP: Characterization of the WAVE1 knock-out mouse: implications for CNS development. J Neurosci 2003, 23:3343-3352
  8. Soderling SH, Langeberg LK, Soderling JA, Davee SM, Simerly R, Raber J, Scott JD: Loss of WAVE-1 causes sensorimotor retardation and reduced learning and memory in mice. Proc Natl Acad Sci USA: 2003, 100:1723-1728
  9. Fukata Y, Itoh TJ, Kimura T, Me ´nager C, Nishimura T, Shiromizu T, Watanabe H, Inagaki N, Iwamatsu A, Hotani H, Kaibuchi K: CRMP-2 binds to tubulin heterodimers to promote microtubule assembly. Nat Cell Biol 2002, 4:583-591
  10. Kawano Y, Yoshimura T, Tsuboi D, Kawabata S, Kaneko-Kawano T, Shirataki H, Takenawa T, Kaibuchi K: CRMP-2 is involved in kinesin- 1-dependent transport of the Sra-1/WAVE1 complex and axon forma- tion. Mol Cell Biol 2005, 25:9920 -9935
  11. Yoshida H, Watanabe A, Ihara Y: Collapsin response mediator pro- tein-2 is associated with neurofibrillary tangles in Alzheimer's dis- ease. J Biol Chem 1998, 273:9761-9768
  12. Gu Y, Hamajima N, Ihara Y: Neurofibrillary tangle-associated collap- sin response mediator protein-2 (CRMP-2) is highly phosphorylated on Thr-509, Ser-518, and Ser-522. Biochemistry 2000, 39:4267-4275
  13. Kitamura Y, Shimohama S, Kamoshima W, Ota T, Matsuoka Y, Nomura Y, Smith MA, Perry G, Whitehouse PJ, Taniguchi T: Alteration of proteins regulating apoptosis. Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease. Brain Res 1998, 780:260 -269
  14. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM: Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular A␤ and synaptic dysfunction. Neuron 2003, 39:409 -421
  15. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G: Correlative memory deficits, A␤ elevation, and amy- loid plaques in transgenic mice. Science 1996, 274:99 -102
  16. Lewis J, McGowan E, Rockwood J, Melrose H, Nacharaju P, Van Slegtenhorst M, Gwinn-Hardy K, Paul Murphy M, Baker M, Yu X, Duff K, Hardy J, Corral A, Lin WL, Yen SH, Dickson DW, Davies P, Hutton M: Neurofibrillary tangles, amyotrophy and progressive motor distur- bance in mice expressing mutant (P301L) tau protein. Nat Genet 2000, 25:402-405
  17. Takata K, Kitamura Y, Tsuchiya D, Kawasaki T, Taniguchi T, Shimohama S: High mobility group box protein-1 inhibits microglial A␤ clearance and enhances A␤ neurotoxicity. J Neurosci Res 2004, 78:880 -891
  18. Hirata-Fukae C, Li HF, Hoe HS, Gray AJ, Minami SS, Hamada K, Niikura T, Hua F, Tsukagoshi-Nagai H, Horikoshi-Sakuraba Y, Mughal M, Rebeck GW, LaFerla FM, Mattson MP, Iwata N, Saido TC, Klein WL, Duff KE, Aisen PS, Matsuoka Y: Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model. Brain Res 2008, 1216:92-103
  19. Arioka M, Tsukamoto M, Ishiguro K, Kato R, Sato K, Imahori K, Uchida T: Tau protein kinase II is involved in the regulation of the normal phosphorylation state of tau protein. J Neurochem 1993, 60:461-468
  20. Uchida Y, Ohshima T, Sasaki Y, Suzuki H, Yanai S, Yamashita N, Nakamura F, Takei K, Ihara Y, Mikoshiba K, Kolattukudy P, Honnorat J, Goshima Y: Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of com- mon phosphorylating mechanism underlying axon guidance and Alz- heimer's disease. Genes Cells 2005, 10:165-179
  21. Ryan KA, Pimplikar SW: Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain. J Cell Biol 2005, 171:327-335
  22. Cole AR, Noble W, van Aalten L, Plattner F, Meimaridou R, Hogan D, Taylor M, LaFrancois J, Gunn-Moore F, Verkhratsky A, Oddo S, LaFerla F, Giese KP, Dineley KT, Duff K, Richardson JC, Yan SD, Hanger DP, Allan SM, Sutherland C: Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's dis- ease progression. J Neurochem 2007, 103:1132-1144
  23. Perry G, Richey PL, Siedlak SL, Smith MA, Mulvihill P, DeWitt DA, Barnett J, Greenberg BD, Kalaria RN: Immunocytochemical evidence that the ␤-protein precursor is an integral component of neurofibrillary tangles of Alzheimer's disease. Am J Pathol 1993, 143:1586 -1593
  24. Fein JA, Sokolow S, Miller CA, Vinters HV, Yang F, Cole GM, Gylys KH: Co-localization of amyloid beta and tau pathology in Alzheimer's disease synaptosomes. Am J Pathol 2008, 172:1683-1692
  25. Smith MA, Siedlak SL, Richey PL, Mulvihill P, Ghiso J, Frangione B, Tagliavini F, Giaccone G, Bugiani O, Praprotnik D, Kalaria RN, Perry G: Tau protein directly interacts with the amyloid ␤-protein precursor: implications for Alzheimer's disease. Nat Med 1995, 1:365-369
  26. Fulga TA, Elson-Schwab I, Khurana V, Steinhilb ML, Spires TL, Hyman BT, Feany MB: Abnormal bundling and accumulation of F-actin medi- ates tau-induced neuronal degeneration in vivo. Nat Cell Biol 2007, 9:139 -148
  27. Ma QL, Yang F, Calon F, Ubeda OJ, Hansen JE, Weisbart RH, Beech W, Frautschy SA, Cole GM: P21-activated kinase aberrant activation and translocation in Alzheimer's disease pathogenesis. J Biol Chem 2008, 283:14132-14143

Cited by

Sorted by citations

Authors
Takata, K., Kitamura, Y., Nakata, Y., Matsuoka, Y., Tomimoto, H., Taniguchi, T., & Shimohama, S.
Affiliations
  • Kyoto Pharmaceutical University (JP)
  • Georgetown University Medical Center (US)
  • Mie University (JP)
  • Sapporo Medical University (JP)
Corresponding author
  • Kitamura, Yoshihisa
  • Shimohama, Shun
Venue
The American Journal of Pathology
Publisher
Elsevier BV
Published
2009-07
Volume
175
Issue
1
Pages
17-24
ISSN
0002-9440 (ISSN-L)
OpenAlex
W2050106520
Cited by
36
References
2
Citations by year
2025: 1 · 2023: 1 · 2022: 1 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 1 · 2016: 3 · 2015: 5 · 2014: 1 · 2013: 6 · 2012: 7
FWCI
2.73
Type
journal article
Language
en
Open access
Locations
  • American Journal Of Pathology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Ministry of Education, Culture, Sports, Science and Technology
  • University of Tokyo
  • Japan Society for the Promotion of Science
  • National Institute on Aging (R01AG026478, AG022455, K01AG022455, AG026478)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
waves, Alzheimer's disease, neurofibrillary tangles, amyloid plaques, tau hyperphosphorylation, CRMP2, actin cytoskeleton, synaptic dysfunction, Tg2576 mice, 3xTg-AD mice
MeSH terms
Aged, Alzheimer Disease, Animals, Brain, Humans, Image Processing, Computer-Assisted, Immunohistochemistry, Mice, Transgenic, Nerve Tissue Proteins, Phosphorylation, Blotting, Western, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Neurofibrillary Tangles, tau Proteins, Microscopy, Confocal, Intercellular Signaling Peptides and Proteins, Immunoprecipitation, Wiskott-Aldrich Syndrome Protein Family, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review